Puma Biotechnology (PBYI) Depreciation and Depletion (2011 - 2026)
Puma Biotechnology (PBYI) posted Depreciation and Depletion of $100000.0 for Q1 2026, little changed on a QoQ basis from $100000.0 in Q4 2025, and little changed year-over-year from $100000.0 in Q1 2025.
Puma Biotechnology (PBYI) Depreciation and Depletion (2011 - 2026) Analysis & Trends
Puma Biotechnology's Depreciation and Depletion history runs 9 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- Quarterly Depreciation and Depletion changed 0.0% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $400000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $400000.0, changed 0.0% from the prior year.
- Depreciation and Depletion was $100000.0 for Q1 2026 at Puma Biotechnology, roughly flat from $100000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $200000.0 in Q1 2022 and bottomed at $100000.0 in Q2 2022.
- A 5-year average of $111764.7 and a median of $100000.0 in 2022 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 0.0% in 2022, while the deepest fall reached 50.0% in 2022.
- Puma Biotechnology's Depreciation and Depletion stood at $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
- Business Quant data shows PBYI's Depreciation and Depletion at $100000.0 in Q1 2026, $100000.0 in Q4 2025, and $100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | - |
| 10 | Puma Biotechnology | 412.35 Mn | 374.07 Mn | 34.39 Mn | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |